Evidence map›Paper›PMID 42161504›Full record

ArticleTobacco control2026

Water addition to e-liquids to reduce flavour aldehyde acetal formation: chemistry and user sensory experience and appeal.

Danielle Davis, Barry G Green, Suchitra Krishnan-Sarin, Thomas D Martin, Ran Wu, Ralitza Gueorguieva, Paul T Anastas, Julie B Zimmerman, Stephanie O'Malley, Whitney Allen and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05257109 (Water Content In E-Liquids), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05257109 nacompletednot on this map

Water Content In E-Liquids

TypeinterventionalSponsorYale UniversityRan2022 to 2023Enrolled31ConditionsNicotine E-Cigarette UseArmsWater Concentration 1, Water Concentration 2, Water Concentration 3, Water Concentration 4
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Danielle DavisPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Barry G GreenJohn B Pierce Laboratory, New Haven, Connecticut, USA.
Suchitra Krishnan-SarinPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0002-3272-9782
Thomas D MartinYale College, New Haven, Connecticut, USA.
Ran WuPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0003-2331-817X
Ralitza GueorguievaCenter for the Study of Tobacco Product Use and Addiction, Yale School of Medicine, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0003-0944-5973
Paul T AnastasYale School of Public Health, New Haven, Connecticut, USA.
Julie B ZimmermanCenter for the Study of Tobacco Product Use and Addiction, Yale School of Medicine, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0002-5392-312X
Stephanie O'MalleyPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Whitney AllenPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Hanno C ErythropelCenter for the Study of Tobacco Product Use and Addiction, Yale School of Medicine, New Haven, Connecticut, USA Hanno.Erythropel@yale.edu.ORCID http://orcid.org/0000-0003-3443-9794

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI TORE EID · 2018 to 2026
$41.6M
Sex Differences in E-Cigarette Flavor Sensory Perception As It Relates to Appeal and Reinforcing Efficacy Among Adult SmokersK01DA056494 · NIDA · YALE UNIVERSITY · PI Danielle R Davis · 2022 to 2026
$965k
NIDA NIH HHS K01 DA056494NIDA NIH HHS U54 DA036151
6 · The paper itself

Abstract

backgroundAldehydes are common e-liquid flavourants that undergo chemical reactions with the e-liquid solvents propylene glycol (PG) and glycerol (G) to form acetals. Some flavour aldehyde PG acetals are respiratory irritants and may have negative user effects. Water-a byproduct of acetal formation-can shift the chemical equilibrium back towards the flavour aldehydes. This study combined chemical and human experiments to assess effects of water addition on acetal formation in laboratory-made e-liquids, commercial products and user experience.

methodsAcetal content was monitored in laboratory-made e-liquids containing PG and one flavour aldehyde (benzaldehyde, cinnamaldehyde, ethylvanillin and vanillin) and commercial e-liquids based on PG/G with corresponding flavours (Cherry, Cinnamon, Vanilla and Grape as non-aldehyde-containing control) containing 0%-20% water over 28 days. E-cigarette users (n=30, 35.3 years (10.4), 51.7% female) assessed sensory and appeal outcomes of the diluted commercial e-liquids (no-added-water, 5%, 10% and 20%). Mixed-effects models assessed main effects of water, flavour and interactions.

resultsWater addition reduced PG-acetal buildup in laboratory-made e-liquids 1.3-38-fold depending on water content (more water was more effective) and flavour aldehyde (vanillin>ethylvanillin>cinnamaldehyde>benzaldehyde). Water addition to commercial e-liquids reversed combined PG/G-acetal content up to 26-fold. Among e-cigarette users, 20% water content (but not 5% and 10%) significantly lowered liking and reward (vs no-added-water). Water addition did not impact sensory outcomes.

conclusionsWater appears to have a limited effect on appeal at ≤10%, while reducing flavour aldehyde acetal formation. Therefore, water addition to e-liquids may be an elegant regulatory approach to reduce exposure to potentially harmful flavour aldehyde acetals in e-cigarettes. TRIAL REGISTRATION NUMBER: NCT05257109.

Indexed as

Electronic nicotine delivery devicesGlobal healthNon-cigarette tobacco productsPublic policyToxicology

Identifiers

PMID42161504
PMCPMC13330406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.